SUMMER SALE COA VERIFIED

Retatrutide 10 mg

Multi-receptor agonist research peptide, lyophilized for in-vitro study.

$59.99$44.99You save $15.00

In stock — orders placed before 2:00 PM ship the same business day.

What does it do?

COMMONLY STUDIED

An investigational triple-receptor agonist peptide studied at GLP-1, GIP and glucagon receptors.

Triple receptor agonism

Binds GLP-1, GIP and glucagon receptors in pharmacology assays.

Metabolic research endpoints

Clinical trial literature reports body-weight and metabolic endpoints in humans.

Glycaemic signalling

Studied for insulin-secretion and glucose-handling pathways in trial settings.

Energy expenditure pathways

Glucagon-receptor activity is investigated for effects on energy metabolism.

Long-acting design

Engineered for extended half-life relative to native incretin peptides.

Explore More

QUALITY & TESTING

99.556% MEASURED PURITY

Third-party HPLC result reported by Janoshik Analytical.

Testing laboratory: Janoshik Analytical
Test date: 2026-07-24
Lot number: #209088
Assay result: 10.96 mg Retatrutide (GLP-1 blind panel)
Verification key: 6XAIT1PYS2CN
Analysis: HPLC purity, MS identity

Download COA

Retatrutide is supplied as a lyophilized research peptide for in-vitro investigation of multi-receptor signalling. Each vial is sealed under inert conditions and released against a documented specification with an accompanying COA.

RESEARCH CONTEXT

Evaluated in preclinical laboratory models for receptor signalling research.

Reference: published preclinical literature; no human data.

Products sold by Peplabs are intended solely for legitimate laboratory research and are not intended for human or veterinary use, diagnosis, treatment, or prevention of disease.